↓ Skip to main content

Effects of EGIS-7625, a Selective and Competitive 5-HT2B Receptor Antagonist

Overview of attention for article published in Cardiovascular Drugs and Therapy, September 2003
Altmetric Badge

Mentioned by

wikipedia
6 Wikipedia pages

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
17 Mendeley
Title
Effects of EGIS-7625, a Selective and Competitive 5-HT2B Receptor Antagonist
Published in
Cardiovascular Drugs and Therapy, September 2003
DOI 10.1023/b:card.0000015857.96371.43
Pubmed ID
Authors

Anikó Kovács, Istvan Gacsályi, János Wellmann, Éva Schmidt, Zsuzsanna Szücs, Valérie Dubreuil, Jean Paul Nicolas, Jean Boutin, Daniel Bózsing, Andras Egyed, Kasoly Tihanyi, Michael Spedding, Gábor Szénási

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 17 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 4 24%
Researcher 3 18%
Professor > Associate Professor 3 18%
Other 2 12%
Student > Bachelor 1 6%
Other 2 12%
Unknown 2 12%
Readers by discipline Count As %
Chemistry 4 24%
Medicine and Dentistry 4 24%
Pharmacology, Toxicology and Pharmaceutical Science 3 18%
Agricultural and Biological Sciences 2 12%
Biochemistry, Genetics and Molecular Biology 1 6%
Other 0 0%
Unknown 3 18%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 November 2023.
All research outputs
#8,759,452
of 25,837,817 outputs
Outputs from Cardiovascular Drugs and Therapy
#248
of 785 outputs
Outputs of similar age
#19,533
of 55,315 outputs
Outputs of similar age from Cardiovascular Drugs and Therapy
#1
of 3 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 785 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.6. This one is in the 42nd percentile – i.e., 42% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 55,315 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 11th percentile – i.e., 11% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them